Showing results (1-10 of 130) with videos related to
Sort By:
Pageof 13
Pharmaceuticals (Basel, Switzerland)|January 8, 2025
Medicinal Cannabis and the Intestinal MicrobiomeLuis Vitetta, Tamara Nation, Debbie Oldfield, et al.Microorganisms|August 3, 2019
Gut Dysbiosis and the Intestinal Microbiome: Streptococcus thermophilus a Key Probiotic for Reducing UremiaLuis Vitetta, Hannah Llewellyn, Debbie OldfieldFrontiers in Bioscience (Elite Edition)|June 28, 2024
Inflammatory Bowel Diseases and the Efficacy of Probiotics as Functional FoodsLuis Vitetta, Debbie Oldfield, Avni SaliIntegrative Cancer Therapies|August 24, 2018
Adjunctive Treatments for the Prevention of Chemotherapy- and Radiotherapy-Induced MucositisMichael Thomsen, Luis VitettaCurrent Opinion in Clinical Nutrition and Metabolic Care|July 24, 2019
Zinc deficits, mucositis, and mucosal macrophage perturbation: is there a relationship?Michael Thomsen, Luis VitettaJournal of Cellular Biochemistry|November 17, 2018
Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probioticsJiezhong Chen, Michael Thomsen, Luis VitettaFrontiers in Microbiology|February 15, 2018
Intestinal Microbiome Shifts, Dysbiosis, Inflammation, and Non-alcoholic Fatty Liver DiseaseEmma T Saltzman, Talia Palacios, Michael Thomsen, et al.Marine Drugs|July 1, 2017
Perna canaliculus and the Intestinal MicrobiomeEmma Tali Saltzman, Michael Thomsen, Sean Hall, et al.Gut Microbes|January 13, 2017
Probiotics, D-Lactic acidosis, oxidative stress and strain specificityLuis Vitetta, Samantha Coulson, Michael Thomsen, et al.Inflammopharmacology|June 26, 2024
An exploratory study of a multi-species probiotic formulation and markers of health in a real-world oncological cohort in the time of covidMichael Thomsen, Ravichandra Vemuri, Flavia Huygens, et al.Pageof 13